These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 190571)

  • 1. The effect of conjugated estrogens on coagulability in menopausal women.
    Stangel JJ; Innerfield I; Reyniak JV; Stone ML
    Obstet Gynecol; 1977 Mar; 49(3):314-6. PubMed ID: 190571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation and fibrinolysis in estrogen-treated surgically menopausal women.
    Notelovitz M; Kitchens CS; Ware MD
    Obstet Gynecol; 1984 May; 63(5):621-5. PubMed ID: 6326012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugated estrogens and hypercoagulability.
    von Kaulla E; Droegemueller W; von Kaulla KN
    Am J Obstet Gynecol; 1975 Jul; 122(6):688-92. PubMed ID: 168774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural oestrogen replacement therapy and blood clotting.
    Poller L
    Postgrad Med J; 1976; 52 Suppl 6():28-9. PubMed ID: 185605
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR; Melo RN; Gebara OC; D'Amico EA; Nussbacher A; Halbe HW; Pinotti JA
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 'natural' oestrogen replacement therapy on menopausal symptoms.
    Coope J
    Postgrad Med J; 1976; 52 Suppl 6():27. PubMed ID: 185604
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation activation following estrogen administration to postmenopausal women.
    Caine YG; Bauer KA; Barzegar S; ten Cate H; Sacks FM; Walsh BW; Schiff I; Rosenberg RD
    Thromb Haemost; 1992 Oct; 68(4):392-5. PubMed ID: 1333098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceruloplasmin serum level in post-menopausal women treated with oral estrogens administered at different times.
    Clemente C; Russo F; Caruso MG; Giangrande M; Fanizza G; Di Leo A
    Horm Metab Res; 1992 Apr; 24(4):191-3. PubMed ID: 1318259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of natural oestrogens on coagulation.
    Notelovitz M; Greig HB
    S Afr Med J; 1975 Jan; 49(4):101-5. PubMed ID: 164700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen replacement therapy and coagulation: relationship to lipid and lipoprotein changes.
    Kessler CM; Szymanski LM; Shamsipour Z; Muesing RA; Miller VT; LaRosa JC
    Obstet Gynecol; 1997 Mar; 89(3):326-31. PubMed ID: 9052579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal treatment of the menopause and vascular pathology].
    Rozenbaum H
    J Mal Vasc; 1984; 9 Suppl A():32-4. PubMed ID: 6330256
    [No Abstract]   [Full Text] [Related]  

  • 12. [Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens].
    Winkler UH; Krämer R; Kwee B; Schindler AE
    Zentralbl Gynakol; 1995; 117(10):540-8. PubMed ID: 7491837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination estrogen and progestogen replacement therapy does not adversely affect coagulation.
    Notelovitz M; Kitchens C; Ware M; Hirschberg K; Coone L
    Obstet Gynecol; 1983 Nov; 62(5):596-600. PubMed ID: 6621949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogens and the menopausal patient.
    Med Lett Drugs Ther; 1973 Jan; 15(2):6-8. PubMed ID: 4348858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
    Skouby SO; Sidelmann JJ; Nilas L; Jespersen J
    Hum Reprod; 2007 Apr; 22(4):1186-91. PubMed ID: 17204528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of DNA damage in postmenopausal women under hormone replacement therapy.
    Ozcagli E; Sardas S; Biri A
    Maturitas; 2005 Jul; 51(3):280-5. PubMed ID: 15978971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles.
    Barrett-Connor E; Young R; Notelovitz M; Sullivan J; Wiita B; Yang HM; Nolan J
    J Reprod Med; 1999 Dec; 44(12):1012-20. PubMed ID: 10649811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium.
    Gelfand MM; Ferenczy A
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):398-402. PubMed ID: 2548135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugated estrogens shorten bleeding time in uraemia: a possible role of serotonin?
    Malyszko JS; Malyszko J; Azzadin A; Buczko W; Mysliwiec M
    Thromb Haemost; 1995 Jan; 73(1):164-5. PubMed ID: 7740490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.